1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Class
• Market Snippet, By Disease
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Rising prevalence of infectious diseases
• Advancement in antibiotic resistance diagnosis
• Growing number of R&D activities
• Key Highlights
• Guidelines for the Temporary Staffing Agency & the Host Employer
• Market Trends
• PEST Analysis
• Investments and Fundings
• Mergers, Acquisitions, and Collaborations
• Key Services Offered
• Identification of Top Market Players
• Nurse Staffing Dominance
• Healthcare Spending by Country

4. Global Antibiotic Resistance Market, By Drug Class, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Oxazolidinones
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Lipoglycopeptides
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Tetracyclines
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cephalosporins
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (Combination therapies, etc.)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Antibiotic Resistance Market, By Disease, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• cUTI (Complicated Urinary Tract Infections)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• CDI (Clostridioides difficile Infection)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• ABSSSI (Acute bacterial skin and skin structure infections)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• HABP (Hospital-acquired bacterial pneumonia)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• CABP (Community-acquired pneumonia)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• cIAI (Complicated intra-abdominal infection)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (BSI (Bloodstream infection), etc.)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Antibiotic Resistance Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Antibiotic Resistance Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2022 – 2033
• Country Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Disease, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By    Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Company Profile
• Melinta Therapeutics
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Merck & Co., Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Allergan
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Tetraphase Pharmaceutical, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• TeamHealth
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Theravance Biopharma
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• WOCKHARDT
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Entasis Threapeutics
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Paratek Pharmaceutials, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Seres Therapeutics
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Achaogen Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Basilea Pharmaceutical Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Nabriva Threapeutics plc
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• NEMESIS BIOSCIENCE LTD.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

9. Section

• References
• Research Methodology
• About us